eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements
Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements
Document ID:
FDA-2008-N-0334-0001
Document Type:
Proposed Rule
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
E9-19682
CFR Citation:
21 CFR 600;314;21 CFR 310
View Document:
Details Information
Document Subtype:
NPR-Notice of Proposed Rule-Making
Received Date:
August 20 2009, at 12:08 PM Eastern Daylight Time
Start-End Page:
42184 - 42203
Page Count:
20
Comment Start Date:
August 21 2009, at 12:00 AM Eastern Standard Time
Comment Due Date:
November 19 2009, at 11:59 PM Eastern Standard Time
Comments
View All
Total:
7
jean public - Comment
Posted:
08/24/2009
ID:
FDA-2008-N-0334-0002
Comment Period Closed
Nov 19,2009 11:59 PM ET
Consumer Healthcare Products Association (CHPA) - Comment
Posted:
11/10/2009
ID:
FDA-2008-N-0334-0003
Comment Period Closed
Nov 19,2009 11:59 PM ET
Merck & Co., Inc. - Comment
Posted:
11/10/2009
ID:
FDA-2008-N-0334-0004
Comment Period Closed
Nov 19,2009 11:59 PM ET
Biotechnology Industry Organization (BIO) - Comment
Posted:
11/19/2009
ID:
FDA-2008-N-0334-0005
Comment Period Closed
Nov 19,2009 11:59 PM ET
K & L Gates LLP - Comment
Posted:
11/19/2009
ID:
FDA-2008-N-0334-0006
Comment Period Closed
Nov 19,2009 11:59 PM ET
Related Documents
Total:
0
No documents available.
Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements
Details Information
Comments
View AllPosted: 08/24/2009 ID: FDA-2008-N-0334-0002
Nov 19,2009 11:59 PM ET
Posted: 11/10/2009 ID: FDA-2008-N-0334-0003
Nov 19,2009 11:59 PM ET
Posted: 11/10/2009 ID: FDA-2008-N-0334-0004
Nov 19,2009 11:59 PM ET
Posted: 11/19/2009 ID: FDA-2008-N-0334-0005
Nov 19,2009 11:59 PM ET
Posted: 11/19/2009 ID: FDA-2008-N-0334-0006
Nov 19,2009 11:59 PM ET
Related Documents